The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Oncolytics Biotech Inc

TSX: ONC
Delayed quote

$0.37

Today's change+0.01 +2.78%
Updated February 10 1:55 PM EST. Delayed by at least 15 minutes.
 

Oncolytics Biotech Inc

TSX: ONC
Delayed quote

$0.37

Today's change+0.01 +2.78%
Updated February 10 1:55 PM EST. Delayed by at least 15 minutes.

Oncolytics Biotech Inc up sharply

Oncolytics Biotech Inc closed up sharply Wednesday, rallying $0.01 or 2.78% to $0.37. Although unchanged over the last five days, shares are down 3.90% for the last year to date. This security has underperformed the S&P TSX by 19.98% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.13
Updated February 10 1:55 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue--00--
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense3444
Selling / general / administrative0000
Research & development2233
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total1111
Operating income-3-4-4-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-3-4-4-4
Income after tax-3-4-4-4
Income tax, total0000
Net income-3-4-4-4
Total adjustments to net income--------
Net income before extra. items-3-4-4-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3-4-4-4
Inc. avail. to common incl. extra. items-3-4-4-4
Diluted net income-3-4-4-4
Dilution adjustment000--
Diluted weighted average shares11811510091
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.03-0.04-0.04
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.02-0.03-0.04-0.04